MBIO•Nasdaq granted Mustang Bio an additional 180 days, through April 12, 2027, to meet its $1.00 minimum bid-price requirement after the company failed to regain compliance by October 12, 2026.
Nasdaq granted Mustang Bio the extension on October 13, 2026, after its closing bids remained below $1.00 for 30 consecutive business days. To comply, the company must have a closing bid of at least $1.00 for at least 10 consecutive business days, generally no more than 20. A reverse stock split remains an option; failure to comply by the deadline would trigger a delisting notice, and an appeal would not pause a trading suspension.
